CPIX vs REGN · rev $10.4M vs P/E 14, rev $14.34B
Cumberland Pharmaceuticals Inc (CPIX) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CPIX currently screens at market cap $86.9M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CPIX and REGN stock pages for the full models.
Not investment advice.